Literature DB >> 30553831

More than one-third of systematic reviews did not fully report the adverse events outcome.

Rachael Parsons1, Su Golder2, Ian Watt3.   

Abstract

OBJECTIVES: The aim of the study was to assess the risk for adverse events reporting bias in systematic reviews of health care interventions registered to PROSPERO. STUDY DESIGN AND
SETTING: This study was a retrospective cohort study. Systematic review protocols in PROSPERO were screened and included if they focused on a health care intervention and listed an adverse event as either a primary or secondary outcome. The included systematic reviews were assessed to determine the completeness of reporting for the adverse event outcomes. Any discrepancies in reporting between protocol and review were recorded.
RESULTS: Of 1,376 protocols for systematic reviews sifted, only 524 (38%) listed adverse events outcomes. One hundred eighty-six protocols were published in 2017 and 2018, of which 146 were included in our analysis. Among the included systematic reviews, 65% (95/146) fully reported the adverse event outcomes as intended by the protocol, 8% (12/146) entirely excluded the adverse event outcome, and the remaining 27% (39/146) either partially reported or changed the adverse event outcomes.
CONCLUSION: Sixty-two percent of reviews did not mention adverse events in their protocol, and 35% of PROSPERO-registered systematic reviews had discrepant outcome reporting between the protocol and publication. The findings suggest a need for the encouraged use of harms reporting guidelines and further research into adverse events reporting bias.
Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adverse events; Bias; Harms; Outcome reporting bias; Reporting; Systematic reviews

Mesh:

Year:  2018        PMID: 30553831     DOI: 10.1016/j.jclinepi.2018.12.007

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  7 in total

1.  Opportunities for selective reporting of harms in randomized clinical trials: Selection criteria for non-systematic adverse events.

Authors:  Evan Mayo-Wilson; Nicole Fusco; Hwanhee Hong; Tianjing Li; Joseph K Canner; Kay Dickersin
Journal:  Trials       Date:  2019-09-05       Impact factor: 2.279

2.  Are cancer patients better off if they participate in clinical trials? A mixed methods study.

Authors:  Zandra Engelbak Nielsen; Stefan Eriksson; Laurine Bente Schram Harsløf; Suzanne Petri; Gert Helgesson; Margrete Mangset; Tove E Godskesen
Journal:  BMC Cancer       Date:  2020-05-08       Impact factor: 4.430

3.  Spin in the reporting, interpretation, and extrapolation of adverse effects of orthodontic interventions: protocol for a cross-sectional study of systematic reviews.

Authors:  Pauline A J Steegmans; Nicola Di Girolamo; Reint A Meursinge Reynders
Journal:  Res Integr Peer Rev       Date:  2019-12-19

4.  Serious adverse events following treatment of visceral leishmaniasis: A systematic review and meta-analysis.

Authors:  Sauman Singh-Phulgenda; Prabin Dahal; Roland Ngu; Brittany J Maguire; Alice Hawryszkiewycz; Sumayyah Rashan; Matthew Brack; Christine M Halleux; Fabiana Alves; Kasia Stepniewska; Piero L Olliaro; Philippe J Guerin
Journal:  PLoS Negl Trop Dis       Date:  2021-03-29

5.  Restoring invisible and abandoned trials of gabapentin for neuropathic pain: a clinical and methodological investigation.

Authors:  Evan Mayo-Wilson; Xiwei Chen; Riaz Qureshi; Stephanie Dickinson; Lilian Golzarri-Arroyo; Hwanhee Hong; Carsten Görg; Tianjing Li
Journal:  BMJ Open       Date:  2021-06-30       Impact factor: 2.692

6.  An assessment of the extent to which the contents of PROSPERO records meet the systematic review protocol reporting items in PRISMA-P.

Authors:  Alison Booth; Alex S Mitchell; Andrew Mott; Sophie James; Sarah Cockayne; Samantha Gascoyne; Catriona McDaid
Journal:  F1000Res       Date:  2020-07-27

7.  Descriptive Epidemiology of Safety Events at an Academic Medical Center.

Authors:  Alexandre R Marra; Abdullah Algwizani; Mohammed Alzunitan; Theresa M H Brennan; Michael B Edmond
Journal:  Int J Environ Res Public Health       Date:  2020-01-04       Impact factor: 3.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.